NCT02458079View on ClinicalTrials.gov

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

July 27, 2016

Study Completion Date

July 27, 2016

Conditions
Alcoholic Hepatitis
Interventions
DRUG

Pentoxiphylline

DRUG

Stool microbiota transplantation

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02458079 - Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter